Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » More Study Needed on Protein-Cancer Link
Uncategorized

More Study Needed on Protein-Cancer Link

By medwebFeb 1, 2004
Share
Facebook Twitter Email

More Study Needed on Protein-Cancer Link

A preliminary study suggests that persistent inflammation, as indicated by increased levels of C-reactive protein in the blood, is a risk factor for the development of colon cancer.

However, according to an editorial by Feinberg School of Medicine researcher Boris C. Pasche, MD, the link between chronic inflammation and colon cancer must be further explored before C-reactive protein is confirmed as a risk predictor.

The study and editorial appear in the February 4 issue of the Journal of the American Medical Association.

Dr. Pasche, a hematologist/oncologist, is assistant professor of medicine at the medical school and director of cancer genetics at The Robert H. Lurie Comprehensive Cancer Center of Northwestern University. Dr. Pasche’s co-author on the editorial was Charles N. Serhan, PhD, of Brigham and Women’s Hospital and Harvard Medical School, Boston.

C-reactive protein is produced primarily in the liver and is a marker of inflammation. It was discovered about 70 years ago as a marker of infection in patients with pneumonia. Recent studies have shown that increased levels of C-reactive protein may also be predictive of heart attack and other cardiovascular events and may play a role in the development of some forms of cancer, including colon cancer.

Share. Facebook Twitter Email

Related Posts

Mar 29, 2023

Adolescent Sexual Health Program Receives Funding for Social Marketing Campaign

Mar 29, 2023

Lurie Cancer Center Receives Merit Extension from NCI

Oct 20, 2021

Drug Combination May Reduce Risk of Leukemia Relapse

Mar 26, 2020

Comments are closed.

Latest News

Adolescent Sexual Health Program Receives Funding for Social Marketing Campaign

Mar 29, 2023

The Future of IgE-Mediated Allergy Research and Treatments

Mar 29, 2023

Weintraub Appointed to Illinois Supreme Court Commission on Elder Law

Mar 28, 2023

Investigating Protein’s Role in Hearing Loss

Mar 27, 2023

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230317_NM651
20230317_NM610
20230317_NM569
20230317_NM537
20230317_NM331
20230317_NM323
20230317_NM316
20230317_NM336
20230317_NM626
20230317_NM662
20230317_NM655
20230317_NM642

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.